News Hub | News Direct
Back

peran+perawat+dalam+pencegahan+gagal+ventilasi+pada+pasien+covid+19


Article thumbnail News Release

Spero Clinic Introduces Innovative Noninvasive Approach to Chronic Pain Management

Rev Up Marketers

Fayetteville, Arkansas – The Spero Clinic, located in Fayetteville, Arkansas, has unveiled a groundbreaking approach to addressing chronic pain conditions through natural, non-invasive methods. Renowned for treating complex and challenging conditions such as Fibromyalgia, Ehlers-Danlos Syndrome (EDS), Complex Regional Pain Syndrome ( CRPS ), and Long Covid, the clinic’s unique treatment philosophy is transforming lives by focusing on individualized care and innovative therapies. Founded by Dr. Katinka van der Merwe, the Spero Clinic’s mission is to provide solutions for patients who have exhausted conventional pain management options. By combining advanced therapies with a deep understanding of the autonomic nervous system, the clinic emphasizes the body’s inherent ability to heal itself. A Unique Methodology Focused on the Vagus Nerve Central to the clinic's treatment approach is the stimulation of the vagus nerve, a critical pathway responsible for transmitting signals between the brain and vital organs. In chronic pain conditions, this "highway" often becomes blocked, leading to persistent pain signals. The Spero Clinic’s vagus nerve stimulation (VNS) therapy aims to restore balance within the autonomic nervous system, reducing inflammation and promoting natural healing. In addition to VNS, the clinic offers an array of complementary therapies, including: Magnetic Resonance Therapy – Enhancing cellular function and promoting recovery. Low-Power Electric Stimulation – Addressing nerve and muscle imbalances. Lymphatic Therapy – Improving circulation and reducing inflammation. Neuromuscular Re-education – Restoring functional movement. A Global Impact Since its inception, the Spero Clinic has drawn patients from across the globe seeking relief from years of unresolved pain. Many have experienced remarkable progress through the clinic’s 14-week program, which prioritizes personalized care tailored to each patient’s unique needs. About the Spero Clinic The Spero Clinic specializes in natural, non-invasive treatments for chronic pain and neurological conditions. With a commitment to innovation and evidence-based care, the clinic provides hope to individuals facing the challenges of persistent pain. For more information please visit https://www.thesperoclinic.com/ Contact Details Kaylie Crane Spero Clinic info@thesperoclinic.com Company Website https://www.thesperoclinic.com/

December 09, 2024 12:31 PM Eastern Standard Time

Article thumbnail News Release

Supreme Court Of New York Awards RedHill Biopharma Approx. $8 Million Plus Costs In Breach Of Contract Lawsuit

Benzinga

By Meg Flippin, Benzinga RedHill Biopharma Ltd. (NASDAQ: RDHL), a specialty biopharmaceutical company, won a significant legal and financial victory, announcing a summary judgment in its favor and an award of about $8 million plus costs in its New York Supreme Court case against Kukbo Co. Ltd. o f South Korea. RedHill Biopharma sued Kukbo over a breach of contract related to opaganib, the company’s first-in-class orally administered sphingosine kinase-2 (SPHK2) selective inhibitor with anticancer, anti-inflammatory and antiviral activity, targeting multiple indications. Opaganib has several U.S. government and academic collaborations in place for development for radiation and chemical exposure indications such as Acute Radiation Syndrome (ARS), a phase 2/3 program for hospitalized COVID-19, and a phase 2 program in oncology. Breach Of Contract At The Heart Of Lawsuit The lawsuit stemmed from Kukbo’s failure to make agreed payments to RedHill pursuant to a subscription agreement signed on Oct. 25, 2021, and a subsequent exclusive license agreement inked on March 14, 2022. The two were working to develop opaganib for COVID. The Supreme Court of the State of New York ruled in favor of RedHill Biopharma and, in a summary judgment, ordered Kukbo to pay $8 million, consisting of $6.5 million plus interest amounting to approximately $1.5 million, plus costs. The court dismissed Kukbo’s counterclaims. Kukbo has a right to seek an appeal of the judgment, which may or may not be granted. RedHill intends to pursue its attorneys' fees and collection of the judgment. "RedHill thanks the Court for this crystal-clear judgment, affirming the company's just position from the beginning of the relationship and in making correct provision for full reparation for the contractual breaches,” said Dror Ben-Asher, RedHill’s CEO. Once collected, the summary judgment will give RedHill more cash to develop its pipeline and eliminates a potential overhang on the stock. TipRanks called the ruling a “significant financial victory,” one that highlights RedHill’s adherence to contractual agreements. TipRanks said the end to litigation could boost investor confidence in the company. The positive ruling comes as RedHill Biopharma is making progress in developing opaganib for infectious diseases such as Ebola. Recently, RedHill announced that the U.S. government’s Biomedical Advanced Research and Development Authority (BARDA), a center of the Department of Health and Human Services’ (HHS) Administration for Strategic Preparedness and Response (ASPR), had selected opaganib for development to treat exposure to Ebola virus disease (EBOV). Under the cost-sharing agreement with BARDA, BARDA will provide partial funding for RedHill to further advance opaganib to mitigate infections and contain EBOV outbreaks. In an in vivo EBOV study with the United States Army Medical Research Institute of Infectious Diseases, RedHill Biopharma said opaganib delivered a statistically significant increase in patient survival time when given at 150 mg/kg twice a day. RedHill Biopharma said it’s the first host-directed molecule to show activity in EBOV. Several other U.S. government countermeasures and pandemic preparedness programs have also selected opaganib for evaluation for multiple indications, reports the company. With litigation in the rearview mirror and RedHill Biopharma making progress in developing opaganib, interested investors may want to pay attention to what’s next from this specialty biopharmaceutical company. Featured photo by Scott Graham on Unsplash. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

December 09, 2024 08:00 AM Eastern Standard Time

Image
Article thumbnail News Release

Blockrock's Bitcoin ETF Records Historic Day; Can Viral New Altcoin Also Gain Traction As It Adopts Satoshi's Bitcoin Principles

Cutoshi

On November 19, Blackrock launched its Bitcoin ETF. In just 24 hours, it reached a trading volume of $1.9 billion, sparking excitement throughout the market. With Bitcoin now closing in on $100,000, the altcoin market is building momentum, with projects like Solana reaching all-time highs over the last week. As prices snowball upwards, an innovative new altcoin called Cutoshi is gaining traction. Having recently passed the $1 million raised milestone, this viral altcoin has gained huge spectator attention and been praised for its use of Satoshi’s Bitcoin principles. Cantor Fitzgerald Plans To Launch A Bitcoin Lending Program Leading financial services company Cantor Fitzgerald has announced plans to create a $2 billion Bitcoin lending program. The program will be supported by Tether and will let investors borrow dollars against Bitcoin, blending traditional finance and DeFi. Meanwhile, Hong Kong digital bank ZA Bank has announced the release of cryptocurrency transactions for retail customers. This is the first Asia-based financial institution to offer cryptocurrency transactions, marking a pivotal moment in global cryptocurrency adoption. Currently, Bitcoin is trading at $98,300.22 following a massive 46% monthly increase. During this rally, Bitcoin inflows have rocketed, with Coinmarketcap showing a daily trading volume of ​​$55.38 billion over the last 24 hours. Blackrock Bitcoin ETF Sees $1.9 Billion In 24-Hour Trading Volume The Blackrock Bitcoin ETF made global headlines over the last week after experiencing an unprecedented trading volume. In just 24 hours, trading volume reached $1.9 billion, pushing Bitcoin to new highs of $98,935.03. Known as the iShares Bitcoin Trust ETF (IBIT) the Blackrock Bitcoin ETF saw a massive 354,000 contract trade in 24 hours. According to Eric Balchunas, a senior ETF analyst at Bloomberg, the Blackrock Bitcoin ETF trading volume was "unprecedented for a first day.” Balchunas also stated that most transactions were call options, suggesting that investors anticipate additional price increases for Bitcoin and the Blackrock Bitcoin ETF. The Blackrock Bitcoin ETF marks a major milestone for the DeFi industry and could result in huge institutional investment in 2025. This could have a significant knock-on effect for the rest of the DeFi market, with the Blackrock Bitcoin ETF continuing to see huge inflows. Cutoshi Gains Momentum With Satoshi's Bitcoin Principles Cutoshi is an exciting new altcoin that’s gained significant traction during its presale. Having recently passed $1 million in raised funds, spectators are anticipating huge returns going into 2025. Cutoshi builds on Satoshi’s Bitcoin principles. It looks to combine outstanding utility with the hype of meme coins to empower investors and educate the next generation of DeFi enthusiasts. Using a Chinese Lucky cat theme, Cutoshi introduces a lucrative new decentralized exchange, educational tools, NFTs and a farming program that attracted over 1,300 users in just a few days. The Cutoshi exchange stands out due to its extremely low fees. Investors can make cross-chain transactions with fees of just 0.25%. 80% of these fees are given to liquidity providers and the remaining 20% are used for $CUTO buybacks, after which the tokens are burned. With great passive income options, an active DeFi community and a rapidly growing ecosystem, spectators are bullish about Cutoshi’s growth. $CUTO tokens can currently be purchased for just $0.0259, though with 76% of stage three already sold out, tokens will remain this low for long! For more information on the Cutoshi (CUTO) Presale: https://cutoshi.com/ Join and become a community member: https://twitter.com/CutoshiToken https://t.me/cutoshi Welcome to Cutoshi, the revolutionary meme coin, DeFi hub and educational platform inspired by the Lucky Cat and Satoshi Nakamoto’s teachings. Traditionally, people put the Lucky Cat in their homes and businesses to maximize its lucky powers and bring them good fortune and wealth. Now Cutoshi the Lucky Cat is on the blockchain bringing luck, prosperity, and wealth to your digital assets. Cutoshi is creating a path to financial freedom, for those who choose to honor the power of the Lucky Cat. Supporting the principles of freedom, privacy, anonymity, and monetary empowerment for the masses. Cutoshi aims to bring the benefits of blockchain to everyone. The regulatory environment surrounding cryptocurrencies is evolving and varies across jurisdictions. It is your responsibility to ensure compliance with applicable laws and regulations in your country or region before engaging with Custoshi. Contact Details Cutoshi hello@cutoshi.com Company Website https://cutoshi.com/

November 26, 2024 12:36 PM Central Standard Time

Image
Article thumbnail News Release

COMCAST CELEBRATES 2024 RISE GRANT RECIPIENTS

Comcast Colorado

Yesterday, Comcast brought together more than 100 Comcast RISE recipients, partners, local officials, Comcast leaders and more from across Southern Colorado for Comcast RISE Day: an evening of education, collaboration, networking and recognition. The Comcast RISE program awarded a total of $500,000 in grants along with technology makeovers, marketing assistance, coaching sessions and education resources to 100 small businesses in Southern Colorado this year. Southern Colorado is one of five communities in the nation chosen for the 2024 program. “I’m confident that with the marketing assistance and technology makeover, we can more effectively share the type of experience we offer, increase our occupancy, and ensure more happy guests have a RAD Colorado experience,” said Erin Welch, RISE Grantee and Owner of RAD Hostel in Colorado Springs. Comcast RISE Day was a way to provide ongoing investment and help ensure the long-term success of these small businesses, which are the bedrock of economic growth in their communities. “Thanks to Comcast RISE, I now have an opportunity for a fresh start, and resources to grow my business.” Said Rique Lucero, RISE grantee and Owner of ColorSplashPaintball in Pueblo, CO. “Small businesses are the backbone of our communities, and Comcast is dedicated to the success and empowerment of these local businesses in Southern Colorado.” said J.D. Keller, Regional Senior Vice President, Comcast Mountain West Region. “Our mission for Comcast RISE is to ensure these businesses can prosper, thrive, and create a sustainable impact across Colorado.” Comcast RISE was created in November 2020 to help small businesses hardest hit by COVID-19 by providing the grants and services needed to survive and recover. The program since evolved from helping businesses survive the pandemic, to helping businesses and their communities achieve stronger economic growth. Held at the United States Olympic and Paralympic Museum in Colorado Springs, the event featured networking, a marketplace offering connections to local resources through Colorado Springs Chamber and EDC, the BBB of Southern Colorado, The Pueblo Economic Development Corp., and the Pikes Peak Small Business Development Center, as well as Comcast Business. Robert Thompson, Vice President, Comcast Business in the Mountain West Region, emceed the evening, and we were honored to hear from Jonathan Liebert, CEO/Executive Director, Better Business Bureau of Southern Colorado, who discussed how AI can be a power-up for small businesses. More information is available at https://www.comcastrise.com/. About Comcast RISE: Comcast RISE is part of Project UP, the company’s $1 billion commitment to advance digital equity through programs and community partnerships that connect people to the Internet, advance economic mobility and open doors for the next generation of innovators, entrepreneurs, storytellers and creators. About Comcast Corporation Comcast Corporation (Nasdaq: CMCSA) is a global media and technology company that connects people to moments that matter. We are principally focused on broadband, aggregation, and streaming with over 56 million customer relationships across the United States and Europe. We deliver broadband, wireless, and video through our Xfinity, Comcast Business, and Sky brands; create, distribute, and stream leading entertainment, sports, and news through Universal Filmed Entertainment Group, Universal Studio Group, Sky Studios, the NBC and Telemundo broadcast networks, multiple cable networks, Peacock, NBCUniversal News Group, NBC Sports, Sky News, and Sky Sports; and provide memorable experiences at Universal Parks and Resorts in the United States and Asia. Visit www.comcastcorporation.com for more information. Contact Details Comcast Leslie Oliver +1 303-810-6326 leslie_oliver@comcast.com Company Website https://colorado.comcast.com/

November 21, 2024 11:33 AM Mountain Standard Time

Article thumbnail News Release

BioRestorative Ends Q3 In ‘Strong’ Financial Position, Reports Positive Data For Its Phase 2 BRTX-100 Chronic Back Pain Trial

Benzinga

By Meg Flippin, Benzinga BioRestorative Therapies, Inc. (NASDAQ: BRTX), a regenerative medicine company focused on stem cell-based therapies and products, is advancing toward profitability, narrowing its loss in the third quarter and releasing favorable data for its BRTX-100 treatment for chronic back pain. The third quarter was a busy period for BioRestorative, as it secured a new patent, released what it says is encouraging trial data and continued licensing discussions with a commercial-stage regenerative medicine company – while also reducing its losses. For the three months ending Sept. 30, 2024, BioRestorative posted an operating loss of $2.3 million, marking a 26% year-over-year improvement from $3.1 million in the same period last year. The net loss for the third quarter was $1.1 million, or $0.13 per share. BioRestorative said it ended the quarter in a “very strong financial position” with $13 million in cash and short-term investments. The company had no debt as of the end of the third quarter. “We have continued to execute well across all areas of our business and are looking forward to continuing to update investors on our progress as we close out the remainder of 2024,” says Lance Alstodt, BioRestorative’s chief executive officer. “From an operating perspective, we are thrilled with our third quarter results, as we are seeing initial progress on our path to sustainable profitability, driven by cost containment activities coupled with increased resources dedicated to our commercial programs.” Commercial Programs Making Inroads BioRestorative’s commercial programs got a boost late in the quarter when it announced it obtained a provisional license from the New York State Department of Health (NYSDOH) to process, isolate, expand and preserve allogeneic (non-autologous) donor tissue, including stem cells, for medical research. Previously BioRestorative was licensed by the NYSDOH to act as a tissue bank for the processing of mesenchymal stem cells derived from autologous donors only. “It will significantly enhance our ability to develop an unrivaled clinical pipeline of off-the-shelf cell-based biologic products,” says Alstodt. Meanwhile, the company’s product, ThermoStem®, which uses adipose-derived (brown fat) stem cells to generate new brown fat tissue to target obesity and metabolic disorders, drew attention during the quarter. BioRestorative shared details of the ThermoStem platform at IFATS 2024, the annual industry conference focused on adipose therapeutics and science. BioRestorative believes cell-based therapy candidates generated from its ThermoStem program may allow for lower dosing than GLP-1 obesity drugs or provide an alternative biologic-based treatment. Studies have shown brown fat activation in addition to weight loss, can lead to positive effects on several organs, including the heart, liver and muscle. The company competes with giants like Novo Nordisk (NYSE: NVO), Eli Lilly (NYSE: LLY) and Pfizer (NYSE: PFE) in the space. During the quarter, the Israel Patent Office issued the company a Notice of Allowance for a new patent application covering several fundamental aspects of ThermoStem. It's the 14th international patent. In addition to all that, BioRestorative continued talks for a ThermoStem licensing deal with an undisclosed commercial-stage regenerative medicine company. BRTX-100 Data Encouraging In conjunction with third-quarter earnings, BioRestorative released clinical data for BRTX-100, its autologous stem cell product for chronic lower back pain. It uses a patient’s stem cells, which are harvested, cultured and then injected directly into the affected disc to start the repair process. It’s targeted at the more than 25 million people in the U.S. who suffer from chronic lower back pain each year. Safety and efficacy endpoints from an ongoing phase 2 trial for the treatment of chronic lumbar disc disease (cLDD) were encouraging, BioRestorative reported. The company said no serious adverse events (SAEs) were reported in any of the 10 first patients of the prospective, randomized, double-blinded and controlled study. BioRestorative said there was also no dose limiting toxicity at 26-52 weeks. “Blinded preliminary clinical data of safety and efficacy endpoints from the ongoing phase 2 clinical trial of BRTX-100 in the treatment of cLDD are very encouraging, with patient-reported pain and function outcomes demonstrating a positive trend,” said Alstodt. “Most importantly, at 26 weeks, 70% of the patients are reporting a greater than 30% increase in function and a more than 30% decrease in pain. If data continues with this trend, we are confident that we will hit our efficacy endpoints for the phase 2 trial.” A total of up to 99 eligible subjects will be enrolled at up to 16 clinical sites in the United States. Subjects included in the trial will be randomized 2:1 to receive either BRTX-100 or a placebo. The new blinded preliminary safety and efficacy data from the ongoing phase 2 clinical trial of BRTX-100 was described in a podium presentation at the Orthopaedic Research Society (ORS) Philadelphia Spine Research Society (PSRS) 7th International Spine Research Symposium. From posting encouraging data to narrowing its losses, BioRestorative seems to be making strides on its path to profitability. With more news to come, this may be a story worth paying attention to. To learn more about BioRestorative’s stem cell therapies, click here. Featured photo by National Cancer Institute on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

November 21, 2024 08:45 AM Eastern Standard Time

Image
Article thumbnail News Release

How The Intersection Of Public Health And Politics Can Shift The Societal Landscape

Benzinga

By Kyle Anthony, Benzinga French philosopher Voltaire is credited with saying, “History never repeats itself. Man, always does.” This adage aptly conveys the nature of human beings to repeatedly engage in risky behaviors despite history being a guide as to how said behavior could play out. Evidence of this behavior is arguably front and center now, as many would argue that there is a wave of populist movements occurring globally, coming after the COVID-19 pandemic and the elevated inflation that followed. As detailed in a report published by Goldman Sachs earlier this year, elections in more than 80 nations and territories occurred this year. As noted in the report, a common observation among political scholars is the growing “democratic backsliding” occurring within sovereign states. Democratic backsliding is a process of declining integrity for democratic values or institutions in a political system. Against the backdrop of a challenging economic environment, populist movements appear to be gaining momentum. As such, some voters are seeking alternatives to current parties or policies, which may be leaving traditional incumbents in places like the U.S. and Europe at a disadvantage during this election cycle, potentially setting the stage for less liberal challengers and some populists to succeed. In Europe, the 2024 European Parliament elections saw a significant shift to the right in many countries, and populist parties gained votes and seats across the EU. Similarly, the re-election of Donald Trump is a strong indication of a return to conservatism. Why The Rise In Populism? Though the fast-moving technological developments occurring in our modern society arguably contribute to populism's rise, the COVID-19 pandemic was an inflection point that shifted the global landscape and is viewed by many as an impetus for where we are now. Using history as a guide, research published in the American Journal of Public Health draws a connection between worsening public health and the support for radical political views, using the 1918 influenza pandemic and the rise of Italian fascism as a reference point. The researchers found statistically significant evidence from the quantitative and qualitative analyses conducted to support their thesis. As emphasized in the research’s main findings, “Mussolini’s newspaper tended to blame “others” for the pandemic, such as Spaniards, and portrayed themselves as the voice of the common people against an out-of-touch “elite,” exploiting the health crisis for political gain.” Drawing parallels from the research, the extrapolated idea is that the COVID-19 pandemic boosted populist sentiment in regions where public health declined and mortality rose. As stated in the research’s main findings, “counties where life expectancy stagnated or declined between 1980 and 2014 were more likely to swing toward support for Donald Trump in the 2016 presidential election. Similarly, communities experiencing worsening health in the United Kingdom saw greater support for Brexit. The same association also holds in different historical junctures. For instance, worsening mortality rates in German localities in the early 1930s were positively associated with the rise of the Nazi Party and influenza deaths in 1918 also correlated with the Nazi electoral boost.” Simply put, a decline in public health and the economic hardship it potentially initiates can be a political catalyst that shifts members of society towards more populist ideologues. Populism During A Precarious Period The global economy is presently in a precarious position where technological advancement and innovation could upend many of the accepted practices and concepts of the present. Furthermore, regional conflicts in the Middle East and Eastern Europe (i.e., Russia – Ukraine), for which individuals have passionate opinions, can widen the ideological divide within our society. Given the range of global activities, the move to populism can be viewed as a validation of the Social Cycle Theory, which posits that events and stages of society and history generally repeat themselves in cycles. The rise of populist movements can be a powerful sentiment that could be a deciding factor for voters at the ballot box. While the inevitability of change is often challenging to convey to individuals facing it, humanity is also resilient and able to overcome the odds. Crossroads Summit 2024: Navigating Chaos, Innovate For The Future With so much potential uncertainty ahead, navigating the seeming chaos will likely be top of mind for many investors. It is this chaos that The Crossroads Summit seeks to help investors cut through. The summit gathers leaders from various sectors – including technology, business, geopolitics, education and public policy, among others – to discuss the global economy's critical issues and what the future could bring. Speakers include some of the brightest minds in their industries, including Microsoft’s (NASDAQ: MSFT) chief innovation officer Michael Jabbour, and Wall Street investor Cathie Wood. Panel discussion topics include “Strategic Adaptation: Preparing for Turbulence in the U.S. Landscape,” “Navigating the End of The World: Geopolitics and the Future of America” and “The New Economy: Bitcoin and the Rise of Alternative Hard Assets,” among others. The summit aims to inspire collaborative efforts that bring about meaningful change and identify opportunities in the chaos. Speakers will explore solutions to societal problems by emphasizing empowerment, innovation and entrepreneurship. This year’s broad theme, Navigating Chaos, Innovate For the Future, will focus on the rapid pace of change today, discussing topics like AI advancement, political and economic uncertainty and the increase in armed conflict globally, among others. Presenting thought leaders and visionaries at this year’s summit will share their insights into these themes and talk of innovative potential solutions for the future. The 2024 Crossroads Summit could be an excellent forum for investors and leaders to exchange and receive knowledge and forge relationships based on societal advancement – and prepare themselves to make the most of President-elect Donald Trump’s second term. Gain insights from thought leaders on the America of the near future: get your tickets by clicking here! Featured photo by Kyle Glenn on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

November 21, 2024 08:30 AM Eastern Standard Time

Image
Article thumbnail News Release

Former Advisor to the CIA Who Called 2016 and 2024 Trump Victories Announces Latest Prediction: “America’s Comeback”

Paradigm

Washington D.C, November 20, 2024 — Jim Rickards, renowned economist, bestselling author, and former advisor to the CIA, Pentagon, and White House, is releasing his latest forecast for America’s future under a new Trump administration. Known for accurately predicting Trump’s 2016 and 2024 victories, the COVID-19 crisis, and Biden’s recent exit from the 2024 presidential race, Rickards now predicts what he calls “America’s Comeback” a vision for Trump’s first 100 days in office. According to Rickards, Trump’s plans could initiate a seismic shift in America’s energy landscape, marking a departure from previous green energy policies to a more resilient and independent energy approach. “With Trump returning to the White House, we’re on the brink of a pivotal shift,” Rickards stated. “America’s Comeback Blueprint lays out the strategies I believe are essential for stabilizing our economy, securing our energy resources, and reclaiming American independence.” Key Elements of “America’s Comeback Blueprint” Energy Independence Through Nuclear Innovation Rickards predicts that Trump’s plan will focus on Small Modular Reactors (SMRs), advanced nuclear technology capable of producing reliable, pollution-free energy. This shift, Rickards says, could not only make the U.S. energy independent but also shield the economy from global energy disruptions. Regulatory Overhaul to Enable Swift Energy Deployment Rickards expects Trump to prioritize reforms at the Nuclear Regulatory Commission (NRC), aiming to fast-track the deployment of nuclear technologies. This shift, he says, could pave the way for SMRs to play a central role in American energy production, stabilizing the grid and lowering energy costs. A Proven Track Record of Predictions Jim Rickards has established a reputation for his accurate foresight, drawn from decades of experience in finance, government advising, and intelligence analysis. Highlights of his predictions include: ● Accurately forecasting Trump’s 2016 and 2024 electoral wins, with a precise count in 2024. ● Predicting the COVID-19 pandemic before it became a global crisis. ● Foreseeing Biden’s exit from the 2024 presidential race, another accurate call from his proprietary models. Rickards is regularly featured on major networks such as Fox, CNBC, and Bloomberg, where his analyses inform public understanding of complex financial and geopolitical events. About Jim Rickards Jim Rickards is a distinguished lawyer, economist, and investment banker with more than 50 years of experience advising international finance and government agencies, including the CIA, Pentagon, and White House. Known for his accurate predictions, including the 2008 Great Recession, Trump’s 2016 and 2024 wins, and the COVID-19 pandemic, Rickards is one of the foremost voices in financial forecasting. His latest publication, Strategic Intelligence, provides essential insights for navigating America’s evolving economic and political landscape. To follow new stories and updates from Jim, please visit Paradigm Press Group. Contact Details Paradigm Press Group Derek Warren dwarren@paradigmpressgroup.com Company Website https://paradigmpressgroup.com/

November 20, 2024 03:51 PM Eastern Standard Time

Article thumbnail News Release

Top Black Friday Travel Deals: Start Planning Your Next Vacation with Norwegian Cruise Line

YourUpdateTV

With Black Friday deals already kicking off, now is the best time to get a jump start on your vacation planning for 2025. Norwegian Cruise Line (NCL) just launched its Black Friday promotion, offering travelers 50% off all cruises plus NCL’s new ‘More At SeaTM’ package, which includes unlimited open bar, specialty dining, and Wi-Fi powered by Starlink’s high-speed internet access, so time spent on the ship is just as exciting as exploring bucket-list destinations. Recently, Travel Expert and Editor-in-Chief of Cruise Critic, Colleen McDaniel, teamed up with Norwegian Cruise Line and D S Simon Media on a nationwide satellite media tour to discuss Black Friday travel deals, top destinations for 2025 and why you should consider a cruise for your next vacation. A video accompanying this announcement is available at: https://youtu.be/MT8wcwu8HHg Cruising continues to provide the best value for your vacation dollar, offering accommodations, meals, and entertainment all included in one package. With the ability wake up in a new destination nearly every day, along with the convenience of only needing to unpack once, NCL offers guests the opportunity to see more, do more, and enjoy more while sailing to 450 destinations around the globe. The onboard experience, which includes exclusive industry-leading attractions like the only racetracks at sea, is enhanced by NCL’s new ‘More At SeaTM’ package, which provides over $2,000* of even more added value with newly enhanced offerings including a new beverage package that features 45% more beverage brands across all categories, with over 100 specialty cocktails to choose from; the ability to dine in more specialty restaurants; faster Wi-Fi powered by Starlink with more minutes available to all guests in the stateroom; shore excursion credits and free airfare for the second guest along with third and fourth guests sail free on select sailings. From Europe’s iconic cities to Alaska’s awe-inspiring landscapes, NCL has endless options for guests to experience more of what they love on their vacation. In 2025, NCL will have 11 ships sailing itineraries in the Mediterranean, Northern Europe and Greek Isles, offering an average of 10 hours in each port, and providing guests with a more immersive European vacation. Next summer, NCL’s Alaska season will also feature a variety of ships and itineraries, delivering guests more choices of embarkation ports, accommodation categories and onboard activities for everyone. With NCL’s newest ship, Norwegian Aqua, debuting in 2025, travelers can experience groundbreaking attractions like the world’s first hybrid rollercoaster and waterslide. Plus, with 17 restaurants, 18 bars and lounges, luxurious spa offerings and immersive entertainment, there is something for everyone. For those looking for a last-minute holiday escape, NCL also offers fantastic deals on shorter voyages, including Caribbean cruises from New Orleans and shorter three- to five-day Bahamas sailings from Miami. These itineraries provide the perfect opportunity for travelers to warm up this winter with a quick tropical getaway. For more information or to book your next cruise, visit NCL.com. # # # * More At Sea package value amount varies per sailing. The $2,000 value is based on a 7-day cruise. About Colleen McDaniel Colleen McDaniel is Editor-in-Chief of Cruise Critic, the world’s largest online cruise resource. She considers cruising to be a true passion, having traveled the world by water – from Alaska, the Caribbean and Hawaii, to Europe’s rivers, Antarctica and Africa – on ships of all shapes and sizes. She’s regularly quoted as a cruise expert in media outlets across the country, including outlets like The Associated Press, Good Morning America, CNN, FOX Business, CNBC, The New York Times, Travel + Leisure and Skift. Cruise Critic is the world’s largest cruise reviews and information site, offering a comprehensive resource for cruise travelers -- from first-time cruisers to avid cruise enthusiasts. The site features more than 50M+ opinions, reviews & photos and hosts the world's largest online cruise community. Cruise Critic is a subsidiary of Tripadvisor, Inc. About Norwegian Cruise Line As the innovator in global cruise travel, Norwegian Cruise Line has been breaking the boundaries of traditional cruising for 57 years. Most notably, the cruise line revolutionized the industry by offering guests the opportunity to design their ideal vacation on their preferred schedule with no assigned dining and entertainment times and no formal dress codes. Today, the company offers guests to ‘Experience More at Sea’ by providing them with more to see, more to do and more to enjoy on their vacation. Its fleet of 19 contemporary ships sail to 400 of the world's most desirable destinations, including Great Stirrup Cay, the company's private island in the Bahamas and its resort destination Harvest Caye in Belize. Norwegian Cruise Line not only provides superior guest service from land to sea, but also offers a wide variety of award-winning entertainment and dining options as well as a range of accommodations across the fleet, including solo-traveler staterooms, club balcony suites and The Haven by Norwegian®, the company's ship-within-a-ship concept. For additional information or to book a cruise, contact a travel professional, call 888-NCL-CRUISE (625-2784) or visit www.ncl.com. For the latest news and exclusive content, visit the NCL Newsroom and follow Norwegian Cruise Line on Facebook, Instagram, Tik Tok and YouTube @NorwegianCruiseLine; and Twitter @CruiseNorwegian. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

November 20, 2024 10:14 AM Eastern Standard Time

Video
Article thumbnail News Release

America’s Shortage Of This Metal Keeps Trump Awake At Night

MILIF, PPTA, NOC, BA

With JP Morgan CEO Jamie Dimon warning Washington that China and Russia are seeking to dismantle the Western world, and “World War III has already begun”, access to critical metals that serve as the fuel of America’s military has become the most urgent issue of our time. Critical metals will determine superpower status and global domination. China is winning because it controls the bulk of the world’s critical metals, from mining to refining. Washington has been slow to discover domestic or friendly resources, at a time when the U.S. Army desperately needs them. So, when a North American junior miner emerges as the owner of key critical metals properties in Europe and North America that could provide a new supply of one of these critical metals, the Western world sees hope. The critical metal that is now poised to make or break a global superpower is antimony, and the miner is Military Metals Corp. (CSE:MILI; OTCQB:MILIF) - a little-known company that just put itself on the critical metals map through some smart strategic acquisitions. Antimony (Sb), a critical metalloid, is a key element of the American war machine, essential for communication equipment, night vision goggles, explosives, ammunition, nuclear weapons, submarines, warships, optics, laser sighting, and more, according to U.S. Army Major General (retired) James Marks. Not only does China control nearly half of the world’s antimony production, but it also cut off antimony exports to the U.S. beginning in September this year. The U.S. Army is Now Desperate for Antimony China produces an astonishing ~70% of the world’s rare earth minerals and controls nearly 50% of the global antimony supply. While China was pushing ahead at full speed, America was napping instead of discovering and developing new critical metals reserves. Then, at the height of the trade war, China threatened to restrict the export of some rare earth minerals. It made good on that threat this year, and last: First, with Germanium and Gallium in 2023, and then with antimony in September this year. Now, the U.S. Army has found itself short on an essential element of its military production line, just as war beckons from Europe to the Middle East. And it will need large amounts of antimony to succeed with a new push to ramp up production of artillery shells at newly launched manufacturing facilities after years of destocking. Meanwhile, American manufacturers use more than 50 million pounds of antimony each year for fireproofing compounds, batteries, ammunition, electronics, specialty glass, and other products, according to MetalTech. Now, it’s past time for America to stake its claims on critical metals reserves, and Military Metals (CSE:MILI; OTCQB:MILIF) is helping to do just that. New Antimony Resources for the Coming Critical Demand Surge Military Metals Corp. is on an antimony acquisition binge that’s taken it as far away as EU-member Slovakia, Nova Scotia in Canada, and most recently in the US. It’s planning to help retell the American antimony story by exploring new and re-developing historical venues that could chip away at China’s control over what is essentially a “military metal.”. Military Metals Corp. recently announced that it has purchased one of Europe’s largest antimony deposits in Slovakia with historical resources. In the heart of Central Europe, it’s a promising Soviet-era resource with an initial discovery from the 1950s and prior development in the ‘80s and ‘90s. It’s already seen two phases of exploration, including drilling and adit excavation. Source: Military Metals Corp At the Trojarova Antimony Project, which could turn Slovakia into a European critical minerals hub, Military Metals Corp. says that underground development of this historical resource, funded by the Slovakian government, was shuttered in the 90s “prior to reaching the richest part of the deposit”. Back then, with the Cold War winding down, and antimony already having served its purpose as the hero of World War II, the motivation just wasn’t there. Today, the situation is very different, and EU’S Trojarova project--with a historical resource of over 61,998 tons of antimony worth around $ 2 billion in situ value at today’s spot prices—could now become a military kingmaker. Figure 1 Military Metals Corp. (CSE:MILI; OTCQB:MILIF): But Military Metals Corp. isn’t concentrating all of its effects on a single continent; it's also making huge moves back in North America, in Canada’s famous WWI antimony mine in Nova Scotia. Military Metals Corp. is sitting on a recently acquired historical antimony/gold play, the West Gore Antimony Project—one of Canada’s biggest past-producing antimony mines and a key supplier to the Allied Forces in WWI. It's an impressive historical resource, with historical drilling results demonstrating over 7 meters of 10.6 gpt gold and 3.4% antimony. It’s not stopping there, however. On October 24th, 2024, the company pounced on another opportunity to further consolidate this territory by signing an LOI to acquire more claims flanking West Gore. The move to consolidate territory surrounding West Gore—one of the biggest heroes of WWI—is a strategic move that could tie the junior miner directly to North American defense at a time when prices are skyrocketing. The Antimony Land Rush is a Junior Game This smart, fast-moving investment strategy could, according to Forbes, be the “latest to generate short-term profits of more than 100% on money invested.”. Forbes was right, even if it underestimated the returns. Shares in junior mining stocks focused on antimony have surged recently, netting investors up to 800% returns in a very short time. Australian ASX-listed companies were the first to light up the exchange, with shares in domestic Larvotto Resources Ltd. (ASX:LRV) surging over 800% in the past six months. The Australian government has placed antimony on its critical metals list, and Australian traders are calling it an “antimony party”. But compared to its closet peer, Perpetua Resources (NASDAQ:PPTA), Military Metals Corp. appears to have quite a lot of room to run, based on resource estimates and current valuation. Perpetua is currently valued at around $700 million, with ~90,000 tons of antimony. The U.S. government is in the process of providing a $1.86 billion loan to Perpetua to have their Antimony mine in production by 2029. Military Metals Corp. is valued at only $23 million right now; but its new play in Slovakia is valued at $2 billion in situ of ore at today’s Antimony spot prices that keeps climbing every week. And that’s only one of its new antimony acquisitions. When you add the potential of West Gore in Nova Scotia, valuations could get even more attractive. Pricing Power on the Brink of War Military Metals Corp. CEO Scott Eldridge sees a major antimony supply crunch coming. He’s certainly not alone. “An extreme supply shortage since April has led to the sharpest price rally ever recorded in the antimony market since Fastmarkets started pricing the metal back in the early 1980s,” according to the UK’s Minor Metals Trade Association (MMTA). “The military uses of Sb [antimony] are now the tail that wags the dog. Everyone needs it for armaments so it is better to hang onto it than sell it,” Christopher Ecclestone of London-based Hallgarten & Company recently told the Financial Review, calling it a “sign of the times”. “This will put a real squeeze on the US and European militaries,” Ecclestone added. Germany has essentially been demilitarized, with its own defense ministry estimating it has about 2 days of ammunition if there is a war with Russia, which it expects to happen within the next few years at most. Germany and the EU have mandated 2 million artillery shells to be manufactured by the end of 2025 with a investment of 500,000,000 euros. Indeed, antimony prices have more than tripled since earlier this year from $12,000 per ton to over $38,000. Two major wars are already involving enemies and allies on four continents, and World War III is already underway for all intents and purposes, making Military Metals Corp.’s (CSE:MILI; OTCQB:MILIF) strategic acquisition binge a fast-moving opportunity that continues to expand with every day that China squeezes supply and America is stuck playing catch-up. Everyone from the U.S. Department of Defense to their Western counterparts around the world is now scrambling to secure new supply, and China is determined to keep the critical mineral taps turned off as it hoards the metal necessary to shore up U.S. defenses. Other companies that are worth keeping a close eye on: Perpetua Resources Corp (NASDAQ:PPTA) Perpetua Resources Corp. is at the forefront of domestic efforts to ensure a stable supply of antimony, a critical metal vital to the United States' defense and industrial sectors. Its flagship project, the Stibnite Gold Project in Idaho, is a critical component of America’s response to growing global supply chain vulnerabilities. The Stibnite Gold Project hosts an estimated 148 million pounds of antimony reserves, positioning it as a major domestic source of this essential metal. Beyond its mineral wealth, the project has also received significant federal support, including $59.2 million under the Defense Production Act and a $1.86 billion loan guarantee interest from the Export-Import Bank of the United States. These commitments highlight the strategic importance of Perpetua’s operations in shoring up the nation’s antimony supply. In addition to producing antimony, Perpetua is working to remediate decades of environmental damage from historic mining activity at the Stibnite site. By prioritizing restoration alongside resource extraction, the company is not only addressing critical security needs but also contributing to the region's ecological and economic renewal. Expected to begin production by 2029, Perpetua Resources is poised to play a central role in meeting the U.S. military's demand for antimony, ensuring the continuity of its supply chain for critical applications, from munitions and electronics to advanced technologies. Northrop Grumman (NYSE: NOC) Northrop Grumman is a leading global security company providing innovative systems, products, and solutions in autonomous systems, cyber, C4ISR, space, strike, and logistics and modernization to customers worldwide. With approximately 90,000 employees, Northrop Grumman is a major player in the defense and aerospace industry. The company is known for its expertise in developing cutting-edge technology, including stealth aircraft, unmanned aerial vehicles (UAVs), and missile defense systems. Northrop Grumman is a key partner to the U.S. government and its allies, providing essential capabilities to maintain national security. Northrop Grumman's innovative solutions are critical to addressing the evolving threats of the modern world. The company's work in areas such as cyber security and autonomous systems is helping to shape the future of warfare. Northrop Grumman's commitment to research and development ensures that its customers have access to the latest technology and capabilities. The company's global presence also allows it to support its customers around the world. Northrop Grumman is focused on delivering value to its shareholders through a combination of organic growth and strategic acquisitions. The company is also committed to maintaining a strong balance sheet and returning capital to shareholders through dividends and share repurchases. Northrop Grumman's financial strength and commitment to shareholder value make it an attractive investment opportunity. Boeing (NYSE: BA) Boeing is the world's largest aerospace company and a leading manufacturer of commercial jetliners, defense, space and security systems, and global services. A major player in the global economy, Boeing employs more than 140,000 people across the United States and in more than 65 countries. Boeing's products and tailored services include commercial and military aircraft, satellites, weapons, electronic and defense systems, launch systems, advanced information and communication systems, and performance-based logistics and training. Boeing's commercial airplane business is one of the company's most important divisions. Boeing is the world's leading manufacturer of commercial airplanes, and its products are used by airlines around the world. The company's defense, space & security business is another key part of Boeing's operations. This division provides a wide range of products and services to the U.S. government and its allies. Boeing has faced challenges in recent years, including the grounding of the 737 MAX aircraft and the COVID-19 pandemic. However, the company is committed to overcoming these challenges and continuing to deliver value to its customers and shareholders. Boeing is an iconic American company that plays a vital role in the global aerospace industry. The company's strong track record, diverse portfolio of services, and commitment to innovation make it a valuable partner to governments and businesses around the world. Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performances are not statements of historical fact and may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this action may be identified through the use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and compensated by MIlitary Metals Corp to assist in the production and distribution of this content. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only; you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third-party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Contact Details RazorPitch Mark McKelvie +1 585-301-7700 mark@razorpitch.com Company Website https://razorpitch.com/

November 20, 2024 07:00 AM Eastern Standard Time

Image
1 ... 56789 ... 513